Literature DB >> 19838909

Investigating the MMPI-2 trauma profile in treatment-seeking peacekeepers.

Arthur R Rademaker1, Rolf J Kleber, Miranda E Meijer, Eric Vermetten.   

Abstract

Most available research on MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) scores in combat veterans suffering from posttraumatic stress disorder (PTSD) has focused on Vietnam veterans. No data are available from peacekeepers suffering from PTSD. The aim of this study was to investigate the relationship between PTSD and the MMPI-2 in a sample of 120 treatment seeking peacekeeping veterans. Results show that relative to a non-PTSD reference group, veterans who screened positive for PTSD scored higher on Scales F, 2 (D), 4 (Pd), 6 (Pa), 7 (Pt), 8 (Sc), and 0 (Si) of the MMPI-2. Scales 2 (D), 7 (Pt), and 8 (Sc) were highest in the mean PTSD profile but no 2- or 3-point code type could be defined. Moderate correlations were found between a self-report measure for PTSD symptoms and scores on MMPI-2 clinical scales 1 (Hs), 2 (D), 6 (Pa), 7 (Pt), and 8 (Sc). The MMPI-2 proved to be useful in assessing the broad range of symptoms typically present in trauma populations as well as the severity of posttraumatic morbidity.

Entities:  

Mesh:

Year:  2009        PMID: 19838909     DOI: 10.1080/00223890903230899

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  3 in total

1.  Comparison of Memory Function and MMPI-2 Profile between Post-traumatic Stress Disorder and Adjustment Disorder after a Traffic Accident.

Authors:  Sung-Man Bae; Myoung-Ho Hyun; Seung-Hwan Lee
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-04-24       Impact factor: 2.582

2.  Psychotraumatology in the Netherlands.

Authors:  Eric Vermetten; Miranda Olff
Journal:  Eur J Psychotraumatol       Date:  2013-05-02

3.  Effect of trauma onset on personality traits of politically persecuted victims.

Authors:  Krzysztof Rutkowski; Edyta Dembińska; Jolanta Walczewska
Journal:  BMC Psychiatry       Date:  2016-05-17       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.